Vistagen Therapeutics Inc (VTGN)
4.45
-0.10
(-2.20%)
USD |
NASDAQ |
May 17, 16:00
4.45
0.00 (0.00%)
After-Hours: 20:00
Vistagen Therapeutics Cash from Operations (Quarterly): -4.535M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -4.535M |
| September 30, 2023 | -6.190M |
| June 30, 2023 | -7.891M |
| March 31, 2023 | -7.473M |
| December 31, 2022 | -9.933M |
| September 30, 2022 | -16.34M |
| June 30, 2022 | -15.97M |
| March 31, 2022 | -15.59M |
| December 31, 2021 | -12.05M |
| September 30, 2021 | -11.45M |
| June 30, 2021 | -6.173M |
| March 31, 2021 | -5.282M |
| December 31, 2020 | -4.989M |
| September 30, 2020 | 1.004M |
| June 30, 2020 | -2.807M |
| March 31, 2020 | -2.579M |
| December 31, 2019 | -4.280M |
| September 30, 2019 | -4.137M |
| June 30, 2019 | -4.761M |
| March 31, 2019 | -3.557M |
| December 31, 2018 | -3.907M |
| September 30, 2018 | -3.928M |
| June 30, 2018 | -3.135M |
| March 31, 2018 | -2.604M |
| December 31, 2017 | -2.445M |
| Date | Value |
|---|---|
| September 30, 2017 | -1.876M |
| June 30, 2017 | -2.134M |
| March 31, 2017 | -1.294M |
| December 31, 2016 | -2.095M |
| September 30, 2016 | -2.202M |
| June 30, 2016 | -1.671M |
| March 31, 2016 | -1.310M |
| December 31, 2015 | -1.169M |
| September 30, 2015 | -1.506M |
| June 30, 2015 | -0.8233M |
| March 31, 2015 | -0.8945M |
| December 31, 2014 | -0.341M |
| September 30, 2014 | -0.5216M |
| June 30, 2014 | -1.012M |
| March 31, 2014 | -0.4671M |
| December 31, 2013 | -0.3425M |
| September 30, 2013 | -0.5846M |
| June 30, 2013 | -0.7318M |
| March 31, 2013 | -0.97M |
| December 31, 2012 | -0.9626M |
| September 30, 2012 | -1.234M |
| June 30, 2012 | -0.2962M |
| March 31, 2012 | -0.7186M |
| December 31, 2011 | -1.058M |
| September 30, 2011 | -0.7022M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-16.34M
Minimum
Sep 2022
1.004M
Maximum
Sep 2020
-7.443M
Average
-6.173M
Median
Jun 2021
Cash from Operations (Quarterly) Benchmarks
| Ardelyx Inc | -35.72M |
| Axsome Therapeutics Inc | -53.47M |
| NovaBay Pharmaceuticals Inc | -1.572M |
| Palatin Technologies Inc | -8.607M |
| iBio Inc | -4.706M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.0323M |
| Cash from Financing (Quarterly) | 93.52M |
| Free Cash Flow | -26.12M |
| Free Cash Flow Per Share (Quarterly) | -0.1554 |
| Free Cash Flow to Equity (Quarterly) | -4.568M |
| Free Cash Flow to Firm (Quarterly) | -4.568M |
| Free Cash Flow Yield | -43.60% |